EuResist
EuResist
EuResist (/juːˈrɪzɪst/) is an integrated project funded by the European Commission under the Sixth Framework Programme for research and technological development. The project aims to improve the clinical management of HIV drug resistance and treatment optimization.
Etymology
The term "EuResist" is a combination of "EU", an abbreviation for the European Union, and "Resist", referring to the resistance against HIV.
Overview
EuResist is a network system that predicts the effectiveness of anti-HIV drugs based on the genetic makeup of the virus. It uses a database of HIV sequences and treatment histories from more than 33,000 patients in Europe. The system uses machine learning algorithms to predict the response to treatment based on the genetic sequence of the virus.
Related Terms
- Antiretroviral therapy: Treatment for HIV using medications that slow the rate at which the virus multiplies.
- Drug resistance: When a virus or bacteria changes in a way that reduces or eliminates the effectiveness of drugs designed to cure or prevent infections.
- Genetic sequence: The order of nucleotides in a DNA or RNA molecule, or the order of amino acids in a protein molecule.
- Machine learning: A type of artificial intelligence that allows software applications to become more accurate in predicting outcomes without being explicitly programmed.
External links
- Medical encyclopedia article on EuResist
- Wikipedia's article - EuResist
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski